WOCKPHARMA Wockhardt Ltd Product Launches Announcement 2024 - New Drug Success Wockhardts investigational drug Zaynich (Zidebactam/Cefepime) has successfully treated over 35 patients, including a notable case of meningitis caused by a pan-drug resistant super-bug, showcasing its effectiveness under compassionate use..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Wockhardt Ltd